Literature DB >> 7393792

Thorotrast administration followed by myelofibrosis.

A G Arnold, M H Oelbaum.   

Abstract

A case of myelofibrosis related to thorotrast administration is described. Current concepts of acute myelofibrosis are discussed, as are the varied complications of thorotrast.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7393792      PMCID： PMC2425512          DOI： 10.1136/pgmj.56.652.124

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  11 in total

Review 1.  Inter-relationship between polycythaemia vera, leukaemia and myeloid metaplasia.

Authors:  B Modan
Journal:  Clin Haematol       Date:  1975-06

2.  MALIGNANT MYELOSCLEROSIS.

Authors:  S M LEWIS; L SZUR
Journal:  Br Med J       Date:  1963-08-24

3.  MYELOFIBROSIS WITH MYELOID METAPLASIA IN SURVIVORS OF THE ATOMIC BOMB IN HIROSHIMA.

Authors:  R E ANDERSON; T HOSHINO; T YAMAMOTO
Journal:  Ann Intern Med       Date:  1964-01       Impact factor: 25.391

4.  MALIGNANCY AND OTHER LATE EFFECTS FOLLOWING ADMINISTRATION OF THOROTRAST.

Authors:  J S DA HORTA; L C DA MOTTA; J D ABBATT; M L RORIZ
Journal:  Lancet       Date:  1965-07-31       Impact factor: 79.321

5.  Acute myelofibrosis and acute myeloblastic leukaemia.

Authors:  A R Patel; P C Shah; H L Rhee
Journal:  Br Med J       Date:  1976-11-20

6.  Late changes in peripheral blood after thorotrast administration.

Authors:  A O Langlands; E R Williamson
Journal:  Br Med J       Date:  1967-07-22

7.  Long-term haematological complications of thorotrast.

Authors:  S A Johnson; C J Bateman; M E Beard; J M Whitehouse; A H Waters
Journal:  Q J Med       Date:  1977-04

8.  Malignant myelosclerosis.

Authors:  J Lubin; S Rozen; M Rywlin
Journal:  Arch Intern Med       Date:  1976-02

9.  STROMAL CHANGES IN LEUKAEMIC AND RELATED BONE MARROW PROLIFERATIONS.

Authors:  N G SANERKIN
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

10.  Acute myelofibrosis and malignant hypercalcemia.

Authors:  J A Libnoch; K Ajlouni; W L Millman; A R Guansing; G B Theil
Journal:  Am J Med       Date:  1977-03       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.